<author><surname>Nordin</surname> <given-names>AJ</given-names> </author><title>Primary carcinoma of the fallopian tube: a 20-year literature review</title><source>Obstet Gynecol Surv</source><year>1994</year><volume>49</volume><fpage>349</fpage><lpage>361</lpage>
<author><surname>Tr&#233;tarre</surname> <given-names>B</given-names> </author><author><surname>Remontet</surname> <given-names>L</given-names> </author><author><surname>Menegoz</surname> <given-names>F</given-names> </author><author><surname>Mace-Lesec'h</surname> <given-names>J</given-names> </author><author><surname>Grosclaude</surname> <given-names>P</given-names> </author><author><surname>Buemi</surname> <given-names>A</given-names> </author><title>Ovarian cancer: incidence and mortality in France</title><source>J Gynecol Obstet Biol Reprod (Paris)</source><year>2005</year><volume>34</volume><fpage>154</fpage><lpage>161</lpage>
<author><surname>Baekelandt</surname> <given-names>M</given-names> </author><author><surname>Jorunn Nesbakken</surname> <given-names>A</given-names> </author><author><surname>Kristensen</surname> <given-names>GB</given-names> </author><author><surname>Trope</surname> <given-names>CG</given-names> </author><author><surname>Abeler</surname> <given-names>VM</given-names> </author><title>Carcinoma of the fallopian tube</title><source>Cancer</source><year>2000</year><volume>89</volume><fpage>2076</fpage><lpage>2084</lpage>
<author><surname>Moore</surname> <given-names>KN</given-names> </author><author><surname>Moxley</surname> <given-names>KM</given-names> </author><author><surname>Fader</surname> <given-names>AN</given-names> </author><author><surname>Axtell</surname> <given-names>AE</given-names> </author><author><surname>Rocconi</surname> <given-names>RP</given-names> </author><author><surname>Abaid</surname> <given-names>LN</given-names> </author><title>Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary</title><source>Gynecol Oncol</source><year>2007</year><volume>107</volume><fpage>398</fpage><lpage>403</lpage>
<author><surname>Wethington</surname> <given-names>SL</given-names> </author><author><surname>Herzog</surname> <given-names>TJ</given-names> </author><author><surname>Seshan</surname> <given-names>VE</given-names> </author><author><surname>Bansal</surname> <given-names>N</given-names> </author><author><surname>Schiff</surname> <given-names>PB</given-names> </author><author><surname>Burke</surname> <given-names>WM</given-names> </author><title>Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer</title><source>Cancer</source><year>2008</year><volume>113</volume><fpage>3298</fpage><lpage>3306</lpage>
<author><surname>Deffieux</surname> <given-names>X</given-names> </author><author><surname>Morice</surname> <given-names>P</given-names> </author><author><surname>Thoury</surname> <given-names>A</given-names> </author><author><surname>Camatte</surname> <given-names>S</given-names> </author><author><surname>Duvillard</surname> <given-names>P</given-names> </author><author><surname>Castaigne</surname> <given-names>D</given-names> </author><title>Pelvic and para-aortic lymphatic involvement in tubal carcinoma: topography and surgical implications</title><source>Gynecol Obstet Fertil</source><year>2005</year><volume>33</volume><fpage>23</fpage><lpage>28</lpage>
<author><surname>Tavassoli</surname> <given-names>FA</given-names> </author><author><surname>Devilee</surname> <given-names>P</given-names> </author><source>Pathology and genetics of tumours of the breast and female genital organs (IARC WHO classification of tumours, No 4)</source><year>2003</year><other>Lyon</other><publisher>IARC Press</publisher>
<author><surname>Pectasides</surname> <given-names>D</given-names> </author><author><surname>Pectasides</surname> <given-names>E</given-names> </author><author><surname>Economopoulos</surname> <given-names>T</given-names> </author><title>Fallopian tube carcinoma: a review</title><source>Oncologist</source><year>2006</year><volume>11</volume><fpage>902</fpage><lpage>912</lpage>
<author><surname>Tamimi</surname> <given-names>HK</given-names> </author><author><surname>Figge</surname> <given-names>DC</given-names> </author><title>Adenocarcinoma of the uterine tube: potential for lymph node metastases</title><source>Am J Obstet Gynecol</source><year>1981</year><volume>141</volume><fpage>132</fpage><lpage>137</lpage>
<author><surname>Cormio</surname> <given-names>G</given-names> </author><author><surname>Lissoni</surname> <given-names>A</given-names> </author><author><surname>Maneo</surname> <given-names>A</given-names> </author><author><surname>Marzola</surname> <given-names>M</given-names> </author><author><surname>Gabriele</surname> <given-names>A</given-names> </author><author><surname>Mangioni</surname> <given-names>C</given-names> </author><title>Lymph node involvement in primary carcinoma of the fallopian tube</title><source>Int J Gynecol Cancer</source><year>1996</year><volume>6</volume><fpage>405</fpage><lpage>409</lpage>
<author><surname>di Re</surname> <given-names>E</given-names> </author><author><surname>Grosso</surname> <given-names>G</given-names> </author><author><surname>Raspagliesi</surname> <given-names>F</given-names> </author><author><surname>Baiocchi</surname> <given-names>G</given-names> </author><title>Fallopian tube cancer: incidence and role of lymphatic spread</title><source>Gynecol Oncol</source><year>1996</year><volume>62</volume><fpage>199</fpage><lpage>202</lpage>
<author><surname>Leblanc</surname> <given-names>E</given-names> </author><author><surname>Querleu</surname> <given-names>D</given-names> </author><author><surname>Narducci</surname> <given-names>F</given-names> </author><author><surname>Occelli</surname> <given-names>B</given-names> </author><author><surname>Papageorgiou</surname> <given-names>T</given-names> </author><author><surname>Sonoda</surname> <given-names>Y</given-names> </author><title>Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience</title><source>Gynecol Oncol</source><year>2004</year><volume>94</volume><fpage>624</fpage><lpage>629</lpage>
<author><surname>Maxson</surname> <given-names>WZ</given-names> </author><author><surname>Stehman</surname> <given-names>FB</given-names> </author><author><surname>Ulbright</surname> <given-names>TM</given-names> </author><author><surname>Sutton</surname> <given-names>GP</given-names> </author><author><surname>Ehrlich</surname> <given-names>CE</given-names> </author><title>Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy</title><source>Gynecol Oncol</source><year>1987</year><volume>26</volume><fpage>305</fpage><lpage>313</lpage>
<author><surname>Muntz</surname> <given-names>HG</given-names> </author><author><surname>Tarraza</surname> <given-names>HM</given-names> </author><author><surname>Goff</surname> <given-names>BA</given-names> </author><author><surname>Granai</surname> <given-names>GO</given-names> </author><author><surname>Rice</surname> <given-names>LW</given-names> </author><author><surname>Nikrui</surname> <given-names>N</given-names> </author><title>Combination chemotherapy in advanced adenocarcinoma of the fallopian tube</title><source>Gynecol Oncol</source><year>1991</year><volume>40</volume><fpage>268</fpage><lpage>273</lpage>
<author><surname>Morris</surname> <given-names>M</given-names> </author><author><surname>Gershenson</surname> <given-names>DM</given-names> </author><author><surname>Burke</surname> <given-names>TW</given-names> </author><author><surname>Kavanagh</surname> <given-names>JJ</given-names> </author><author><surname>Silva</surname> <given-names>EG</given-names> </author><author><surname>Wharton</surname> <given-names>JT</given-names> </author><title>Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide</title><source>Obstet Gynecol</source><year>1990</year><volume>76</volume><fpage>1020</fpage><lpage>1024</lpage>
<author><surname>Barakat</surname> <given-names>RR</given-names> </author><author><surname>Rubin</surname> <given-names>SC</given-names> </author><author><surname>Saigo</surname> <given-names>PE</given-names> </author><author><surname>Lewis</surname> <given-names>JL</given-names> <suffix>Jr</suffix> </author><author><surname>Jones</surname> <given-names>WB</given-names> </author><author><surname>Curtin</surname> <given-names>JP</given-names> </author><title>Second-look laparotomy in carcinoma of the fallopian tube</title><source>Obstet Gynecol</source><year>1993</year><volume>82</volume><fpage>748</fpage><lpage>751</lpage>
<author><surname>Peters</surname> <given-names>WA</given-names> <suffix>3rd</suffix> </author><author><surname>Andersen</surname> <given-names>WA</given-names> </author><author><surname>Hopkins</surname> <given-names>MP</given-names> </author><title>Results of chemotherapy in advanced carcinoma of the fallopian tube</title><source>Cancer</source><year>1989</year><volume>63</volume><fpage>836</fpage><lpage>838</lpage>
<author><surname>Pectasides</surname> <given-names>D</given-names> </author><author><surname>Pectasides</surname> <given-names>E</given-names> </author><author><surname>Papaxoinis</surname> <given-names>G</given-names> </author><author><surname>Andreadis</surname> <given-names>C</given-names> </author><author><surname>Papatsibas</surname> <given-names>G</given-names> </author><author><surname>Fountzilas</surname> <given-names>G</given-names> </author><title>Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients</title><source>Gynecol Oncol</source><year>2009</year><volume>115</volume><fpage>97</fpage><lpage>101</lpage>
<author><surname>Roh</surname> <given-names>MH</given-names> </author><author><surname>Kindelberger</surname> <given-names>D</given-names> </author><author><surname>Crum</surname> <given-names>CP</given-names> </author><title>Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?</title><source>Am J Surg Pathol</source><year>2009</year><volume>33</volume><fpage>376</fpage><lpage>383</lpage>
<author><surname>Jarboe</surname> <given-names>EA</given-names> </author><author><surname>Folkins</surname> <given-names>AK</given-names> </author><author><surname>Drapkin</surname> <given-names>R</given-names> </author><author><surname>Ince</surname> <given-names>TA</given-names> </author><author><surname>Agoston</surname> <given-names>ES</given-names> </author><author><surname>Crum</surname> <given-names>CP</given-names> </author><title>Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective</title><source>Histopathology</source><year>2008</year><volume>53</volume><fpage>127</fpage><lpage>138</lpage>
<author><surname>Kindelberger</surname> <given-names>DW</given-names> </author><author><surname>Lee</surname> <given-names>Y</given-names> </author><author><surname>Miron</surname> <given-names>A</given-names> </author><author><surname>Hirsch</surname> <given-names>MS</given-names> </author><author><surname>Feltmate</surname> <given-names>C</given-names> </author><author><surname>Medeiros</surname> <given-names>F</given-names> </author><title>Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship</title><source>Am J Surg Pathol</source><year>2007</year><volume>31</volume><fpage>161</fpage><lpage>169</lpage>
<author><surname>Carlson</surname> <given-names>JW</given-names> </author><author><surname>Miron</surname> <given-names>A</given-names> </author><author><surname>Jarboe</surname> <given-names>EA</given-names> </author><author><surname>Parast</surname> <given-names>MM</given-names> </author><author><surname>Hirsch</surname> <given-names>MS</given-names> </author><author><surname>Lee</surname> <given-names>Y</given-names> </author><title>Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention</title><source>J Clin Oncol</source><year>2008</year><volume>26</volume><fpage>4160</fpage><lpage>4165</lpage>
<author><surname>Crum</surname> <given-names>CP</given-names> </author><author><surname>Drapkin</surname> <given-names>R</given-names> </author><author><surname>Kindelberger</surname> <given-names>D</given-names> </author><author><surname>Medeiros</surname> <given-names>F</given-names> </author><author><surname>Miron</surname> <given-names>A</given-names> </author><author><surname>Lee</surname> <given-names>Y</given-names> </author><title>Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer</title><source>Clin Med Res</source><year>2007</year><volume>5</volume><fpage>35</fpage><lpage>44</lpage>
<author><surname>Semmel</surname> <given-names>DR</given-names> </author><author><surname>Folkins</surname> <given-names>AK</given-names> </author><author><surname>Hirsch</surname> <given-names>MS</given-names> </author><author><surname>Nucci</surname> <given-names>MR</given-names> </author><author><surname>Crum</surname> <given-names>CP</given-names> </author><title>Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria</title><source>Mod Pathol</source><year>2009</year><volume>22</volume><fpage>985</fpage><lpage>988</lpage>
<author><surname>Deligdisch</surname> <given-names>L</given-names> </author><author><surname>Penault-Llorca</surname> <given-names>F</given-names> </author><author><surname>Schlosshauer</surname> <given-names>P</given-names> </author><author><surname>Altchek</surname> <given-names>A</given-names> </author><author><surname>Peiretti</surname> <given-names>M</given-names> </author><author><surname>Nezhat</surname> <given-names>F</given-names> </author><title>Stage I ovarian carcinoma: different clinical pathologic patterns</title><source>Fertil Steril</source><year>2007</year><volume>88</volume><fpage>906</fpage><lpage>910</lpage>